MYC and Miyoshi myopathy: Interestingly these studies highlighted not only the therapeutic potential of both FGF and FGFR inhibitors in MM, but also a strong link between FGF/FGFR signaling activation and c-Myc oncogenic functions in MM cells as discussed below.